The much-adorned pioneer behind CRISPR/Cas9 – MIMS General News (Hong Kong) (registration) (blog)
MIMS General News (Hong Kong) (registration) (blog) |
The much-adorned pioneer behind CRISPR/Cas9
MIMS General News (Hong Kong) (registration) (blog) In 2015, he refined the technology to develop /Cas9-Cpf1; and in 2016, he founded CRISPR/C2c2 to target RNA. His ability to provide defining solutions appears to stem from his ability to mix together information from a multitude of areas. “When I’m … |
gulfnews.com |
Cancer Immunotherapy Market is Projected to Exceed US$ 145 Billion By 2022
Medgadget (blog) Market Research Engine has published a new report titled as “Cancer Immunotherapy Market by Type (Immunomodulators, Checkpoint inhibitors, Cancer vaccines, Monoclonal antibodies), By Application (Melanoma, Colorectal cancer, Prostate cancer, Head … Immunotherapy has changed cancer medicine. But it’s no miracle curegulfnews.com Key to cancer may lie within own bodies but fears grow that ‘wonder drugs’ will be elite-onlyThe National |
|
#IARC2017 (Exclusive Interview) – Gene Therapy Seen to Reverse Sensory Ataxia in FA Mouse Model
Friedreich’s Ataxia News Using a gene therapy strategy similar to one previously shown to reverse heart problems in a Friedreich’s ataxia mouse model, researchers also corrected sensory symptoms associated with the disease in another mouse model. These results suggest that … |
OncLive |
Penn Seeks to Make CAR T-Cell Therapy Work in Solid Tumor Disease
OncLive Chimeric antigen receptor (CAR) T-cell therapy for hematological malignancies took a huge step forward this summer with the FDA approval of Novartis’ tisagenlecleucel (Kymriah) for relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL … |
|
Penn Seeks to Make CAR T-Cell Therapy Work in Solid Tumor Disease
OncLive Chimeric antigen receptor (CAR) T-cell therapy for hematological malignancies took a huge step forward this summer with the FDA approval of Novartis’ tisagenlecleucel (Kymriah) for relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL … |
Leicester Mercury |
Could new stem cell treatment help halt Becky’s MS in its tracks?
Leicester Mercury But a specialist team at London’s Charring Cross Hospital has confirmed she can have the therapy in this country. Becky, from Caldecott in Rutland, has her hopes pinned on the stem cell treatment halting her MS and perhaps even reversing some of the … |
Vancouver Sun |
Conversations That Matter: Stemcell Technologies aims to be world leader
Vancouver Sun This week Conversations That Matter features the remarkable Dr. Allen Eaves, the founder, CEO and president of Stemcell Technologies, Canada’s most successful biotech company. It is is playing a pivotal role in fostering a community of biotech startups. |
Vancouver Sun |
Conversations That Matter: Stemcell Technologies aims to be world leader
Vancouver Sun This week Conversations That Matter features the remarkable Dr. Allen Eaves, the founder, CEO and president of Stemcell Technologies, Canada’s most successful biotech company. It is is playing a pivotal role in fostering a community of biotech startups. |